Ovarian cancer, version 2.2013.


Journal Article

These NCCN Guidelines Insights focus on the major updates to the 2013 NCCN Guidelines for Ovarian Cancer. Four updates were selected based on recent important updates in the guidelines and on debate among panel members about recent clinical trials. The topics include 1) intraperitoneal chemotherapy, 2) CA-125 monitoring for ovarian cancer recurrence, 3) surveillance recommendations for less common ovarian histopathologies, and 4) recent changes in therapy for recurrent epithelial ovarian cancer. These NCCN Guidelines Insights also discuss why some recommendations were not made.

Full Text

Duke Authors

Cited Authors

  • Morgan, RJ; Alvarez, RD; Armstrong, DK; Burger, RA; Chen, L-M; Copeland, L; Crispens, MA; Gershenson, DM; Gray, HJ; Hakam, A; Havrilesky, LJ; Johnston, C; Lele, S; Martin, L; Matulonis, UA; O'Malley, DM; Penson, RT; Powell, MA; Remmenga, SW; Sabbatini, P; Santoso, JT; Schink, JC; Teng, N; Werner, TL; Dwyer, MA; Hughes, M; National comprehensive cancer networks,

Published Date

  • October 1, 2013

Published In

Volume / Issue

  • 11 / 10

Start / End Page

  • 1199 - 1209

PubMed ID

  • 24142821

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2013.0142


  • eng

Conference Location

  • United States